Your weekly roundup of the latest news from Drug Topics®.
OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.
NACDS CEO responds to comments by AMA president.
This can’t-miss event is being held April 30, 2022.
With each new technological advance comes a set of potential downsides and a myriad of ethical dilemmas that must be addressed.
Some patients may benefit from specialized treatment.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.